Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth Katherine Lee, M.D.

Concepts (117)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Elizabeth Lee's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Elizabeth Lee has written about over time.
Genital Neoplasms, Female, 1 publications between 2019 and 2019, average publication date March 2019. Immunoconjugates, 1 publications between 2019 and 2019, average publication date March 2019. Maytansine, 1 publications between 2019 and 2019, average publication date March 2019. Sodium-Phosphate Cotransporter Proteins, Type IIb, 1 publications between 2019 and 2019, average publication date March 2019. Drug Resistance, Neoplasm, 3 publications between 2020 and 2020, average publication date July 2020. Doxorubicin, 1 publications between 2020 and 2020, average publication date August 2020. Cystadenocarcinoma, Serous, 2 publications between 2020 and 2020, average publication date August 2020. Antineoplastic Combined Chemotherapy Protocols, 7 publications between 2019 and 2022, average publication date September 2020. Uterine Neoplasms, 1 publications between 2020 and 2020, average publication date November 2020. Ovarian Neoplasms, 7 publications between 2019 and 2023, average publication date November 2020. Deoxycytidine, 2 publications between 2020 and 2021, average publication date February 2021. Endometrial Neoplasms, 3 publications between 2019 and 2022, average publication date July 2021. Antineoplastic Agents, 2 publications between 2020 and 2023, average publication date September 2021.

To see the data from this visualization as text, click here.
Lee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (117)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.